"Gleason-Score: ≤6 (3+3)"
"Gleason Score: ≤7a (3+4)"
"prostate-specific antigen (PSA)"
"Recommendations as per NICE guidelines (c. 2019) 2:"
"monitoring of PSA/PSAD and PSA velocity: every 3-4 months within the first year, every 6 months after that"
Expected headings
"Indications"